Streetbeat News

Products Services

HPYCF

Happy Creek Minerals Ltd. announced positive results from its 2024 fieldwork at the Silverboss and Hen-DL properties in British Columbia.

Portfolio Pulse from

November 21, 2024 | 2:00 pm

AAAU

Jim Wyckoff, a seasoned financial journalist, provides an analysis of the gold market for November 21, focusing on key intra-day price entry levels for active traders. The article may mention AAAU, a gold ETF.

Portfolio Pulse from

November 21, 2024 | 2:00 pm

CETY

Clean Energy Technologies, Inc. (CETY) has announced a strategic partnership with METIS Power to develop advanced microgrid solutions for AI data centers and cryptocurrency mining operations. This partnership aims to enhance eco-friendly energy solutions in North America, Europe, and Asia.

Portfolio Pulse from

November 21, 2024 | 2:00 pm

FLGC

Flora Growth Corp. has launched Element, a new glass and brass bubbler under its premium lifestyle brand, Vessel. This innovative product is expected to enhance Flora's product lineup.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

ALGN

Align Technology has received a CE mark for its Invisalign Palatal Expander System, which is expected to positively impact its stock (ALGN).

Portfolio Pulse from

November 21, 2024 | 1:45 pm

GEHC

The FDA has cleared the XENOVIEW® 3T Chest Coil for use in GE HealthCare MRI systems, enhancing accessibility for institutions using these systems.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

XBIO

Xenetic Biosciences, Inc. presented positive preclinical data on the co-administration of DNase I with CAR T cells, showing potential in treating melanoma lung metastasis. This data supports the use of DNase I to enhance CAR T cell therapy efficacy.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

GTVH

Golden Triangle Ventures, Inc. (OTC PINK: GTVH) will host an exclusive Spaces call on December 11, 2024, to provide a comprehensive update on Destino Ranch.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

DYAI

Dyadic International has received a $3 million grant from the Bill & Melinda Gates Foundation to develop cost-effective monoclonal antibodies for RSV and malaria using its C1 platform technology. This funding aims to support the creation of affordable therapeutics.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

VGT

The article discusses the potential impact of Artificial General Intelligence (AGI) on the market and recommends a Vanguard ETF as a strategic investment to capitalize on this trend.

Portfolio Pulse from

November 21, 2024 | 1:45 pm